InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,308.13
(
0.09%
)
US TECH 100
18,179.20
(
0.60%
)
Dow Jones
39,806.77
(
-0.49%
)
Brent Oil
83.55
(
0.02%
)
Bitcoin
71,180.36
(
-0.37%
)
Post# of 13
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

BIOTABULL

Send PM Follow Ignore
Followers 0
Posts 25
Boards Moderated 0
Alias Born 12/12/2005

BIOTABULL

Re: None

Thursday, 01/05/2006 8:06:25 AM

Thursday, January 05, 2006 8:06:25 AM

Post# of 13
Lucrative Biota deal 16dec05
SHARES in Biota Holdings rose more that 4 per cent yesterday on news of a deal with U.S. firm MedImmune Inc to develop a compound to prevent and treat respiratory syncytial virus (RSV) infection.

The agreement with the U.S. company will give Biota $6.63 million immediately and reimburse future research and development expenses on the collaborative RSV program.

Biota says it could receive up to $US107.5 million based on certain clinical and regulatory milestones and a royalty on sales of a future licensed product brought to market by MedImmune.

Biota will have exclusive marketing rights in Australia, New Zealand, China, South-East Asia, India and Pakistan for potential products developed as a result of the agreement.



Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up